Stock screener

CTNM

Conviction 47HealthcareScan · Thu, Sep 24, 2026
Hammer

Contineum Therapeutics, Inc. (CTNM) closed at $12.49 (-0.16%) on Sep 24, 2026. Its latest daily candle is a hammer. Price is below its 50-day and below its 200-day moving average. RSI(14) 31, RS Rating 52, -28.9% from its 52-week high, +9.7% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

CTNM$12.49-0.16%
ResistanceSupportVol 14Insider sell
63 bars
2
Vol MA14 678.11K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Contineum Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.contineum-tx.com ↗
Price12.49
Change-0.16%
Gap+1.60%
Rel volume2.43×
Avg volume579.77K
Avg $ vol8.31M
SMA 2015.01
SMA 5015.06
SMA 20013.69
Price vs 50-17.06%
Price vs 200-8.79%
MA stackmixed
50/200 cross—
Supertrenddown · 14.97
RSI (14)31
MACD hist-0.33
MACD cross—
Stoch %K / %D17 / 10
ADX (14)27
+DI / −DI12 / 38
RSI divergenceBearish
MACD divergenceBearish
ATR %7.82%
ADR %6.05%
52w high17.57
52w low9.17
From 52w high-28.91%
Above 52w low+36.21%
New 52w highNo
SqueezeOff
Bollinger width43.88%
%B0.12
Donchian pos17.01%
Donchian high17.79
Donchian low11.41
AVWAP (52w high)13.92
vs AVWAP high-10.27%
AVWAP (52w low)14.01
vs AVWAP low-10.86%
OBV trendDown
Chaikin MF (20)-0.20
Today vs 20d2.43×
Avg vol (14d)678.11K
Avg vol (20d)579.77K
Avg $ vol (20d)8.31M
Market cap288.51M
RS Rating52 / 99
RS 3m (vs SPY)-11.00%
RS 6m (vs SPY)-22.77%
RS line new highNo
Trend template4/8
Technical rank19.0
1 week-5.45%
1 month-26.74%
3 months-6.51%
6 months-5.95%
1 year+12.93%
YTD+9.66%
P/E-4.81
P/B1.20
P/S—
P/FCF-5.19
EPS-2.17
Div yield—
ROE-25.03%
ROA-23.96%
Debt/Eq—
Current37.17
EV/EBITDA-4.04
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-41.93%
Price target22.14
Target upside77.26%
Analyst ratingBuy
Institutional104.79%
Ent. value273.8M
Revenue0
Net income-15.15M
Gross profit—
Free cash flow-55.54M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out32.72M
Employees51
ListedFri, Apr 5, 2024
Free float26.58M
Float %81.2%
Short interest2.34M
Days to cover4.0d
Short volume63.9%
Squeeze score69 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.40 vs −$0.46
Last surprise+13.0% beat
Setup gradeC
Conviction47 / 100
Pattern quality—
Tech rank19.0 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHammer

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CTNM

All disclosures →
No recent disclosed trades by Congress in CTNM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CTNM · open-market 3 sells

InsiderSideShares
Lorrain Daniel S.
Chief Scientific Officer · Class A Common Stock · 2026-07-09
Sell25
Lorrain Daniel S.
Chief Scientific Officer · Class A Common Stock · 2026-07-09
Exercise25
Lorrain Daniel S.
Chief Scientific Officer · Stock Option (right to buy) · 2026-07-09
Exercise25
Lorrain Daniel S.
Chief Scientific Officer · Class A Common Stock · 2026-07-08
Sell1.01K
Lorrain Daniel S.
Chief Scientific Officer · Class A Common Stock · 2026-07-08
Exercise1.01K
Lorrain Daniel S.
Chief Scientific Officer · Stock Option (right to buy) · 2026-07-08
Exercise1.01K
Stengone Carmine N.
CEO and President · Class A Common Stock · 2026-07-08
Exercise2.5K
Stengone Carmine N.
CEO and President · Class A Common Stock · 2026-07-08
Sell2.5K
Stengone Carmine N.
CEO and President · Stock Option (right to buy) · 2026-07-08
Exercise2.5K
Schimmelpennink Evert B.
Director · Stock Option (right to buy) · 2026-06-26
Grant19K

SEC filings

EDGAR filings in CTNM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.